Poxel to Present New Imeglimin and PXL770 Data at the 52nd European Association for the Study of Diabetes Annual Meeting Sep 6, 2016
Poxel Announces Publication of Important New Mechanism Data for Imeglimin Relating to Insulin Secretion in the Treatment of Type 2 Diabetes Jul 26, 2016
Poxel Announces Patient Enrollment Completed for Imeglimin Phase 2b Clinical Trial in Type 2 Diabetes in Japan Jun 30, 2016
Poxel Announces Positive Results From the First Stage of the Ongoing PXL770 Phase 1 Trial Jun 20, 2016
Poxel Presents New Data on Imeglimin’s Dual Mechanism of Action at the American Diabetes Association’s 76th Scientific Sessions Jun 13, 2016
Poxel to Present Imeglimin Data at the American Diabetes Association’s 76th Scientific Sessions May 17, 2016
